Literature DB >> 1704288

Inhibition of calcium currents in cultured myenteric neurons by neuropeptide Y: evidence for direct receptor/channel coupling.

L D Hirning1, A P Fox, R J Miller.   

Abstract

Single channel recordings from rat myenteric plexus neurons demonstrated the presence of two categories of Ca2+ channels. One type of Ca channel had a slope conductance of 27 pS and was sensitive to dihydropyridines while the other channel type had a conductance of 14 pS and was dihydropyridine-insensitive. The 14 pS channel was mostly inactivated at a holding potential of -40 mV, while the 27 pS channel was much more resistant to depolarized holding potentials. A majority of whole-cell current was reprimed by the use of negative holding (-90 mV) potentials, when compared to that obtained at a holding potential of -40 mV. These properties are consistent with N- and L-type Ca channels previously described. In general, the inactivating part of the whole-cell Ca2+ current, selectively reprimed by negative holding potentials, was inhibited by neuropeptide Y (NPY). Depolarization-induced [Ca2+]i transients assessed using fura-2 showed that the inhibitory effects of nitrendipine and NPY were additive. The effects of NPY were abolished by pertussis toxin pretreatment. Single-channel experiments showed that neither the 14 nor the 27 pS Ca channel currents were inhibited by the addition of NPY outside the patch pipette. These results suggest that NPY modulates N-type Ca2+ channels selectively in these neurons and that an easily diffusible second messenger does not appear to participate in receptor/channel coupling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704288     DOI: 10.1016/0006-8993(90)91751-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons.

Authors:  G Chen; A N van den Pol
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

2.  Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor.

Authors:  D Bleakman; W F Colmers; A Fournier; R J Miller
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

3.  Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat.

Authors:  D Bleakman; N L Harrison; W F Colmers; R J Miller
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

4.  The peptide CGRP increases a high-threshold Ca2+ current in rat nodose neurones via a pertussis toxin-sensitive pathway.

Authors:  J W Wiley; R A Gross; R L MacDonald
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

5.  Localization and characterization of neuropeptide Y binding sites in porcine and human colon.

Authors:  D A Walsh; J Wharton; D R Blake; J M Polak
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

6.  Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.

Authors:  K Obrietan; A N van den Pol
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

7.  Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.

Authors:  Z Xiong; B J Bolzon; D W Cheung
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

8.  Melanostatin (NPY) inhibited electrical activity in frog melanotrophs through modulation of K+, Na+ and Ca2+ currents.

Authors:  J A Valentijn; H Vaudry; W Kloas; L Cazin
Journal:  J Physiol       Date:  1994-03-01       Impact factor: 5.182

9.  Changes in osmolality modulate voltage-gated calcium channels in trigeminal ganglion neurons.

Authors:  Lei Chen; Changjin Liu; Lieju Liu
Journal:  Brain Res       Date:  2008-02-29       Impact factor: 3.252

Review 10.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.